Eiger BioPharmaceuticals, Inc. (EIGRQ)
USD 8.5
(6.25%)
USD 8.5
(6.25%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -71.78 Million USD | 22.59% |
| 2022 | -92.74 Million USD | -20.54% |
| 2021 | -76.93 Million USD | -23.8% |
| 2020 | -62.14 Million USD | 9.8% |
| 2019 | -68.9 Million USD | -34.98% |
| 2018 | -51.04 Million USD | -22.95% |
| 2017 | -41.52 Million USD | 9.97% |
| 2016 | -46.12 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | -22.26 Million USD | 9.02% |
| 2023 Q4 | -12.61 Million USD | 25.48% |
| 2023 FY | -71.78 Million USD | 22.59% |
| 2023 Q2 | -19.98 Million USD | 10.25% |
| 2023 Q3 | -16.92 Million USD | 15.28% |
| 2022 Q3 | -26.36 Million USD | -31.32% |
| 2022 Q1 | -21.82 Million USD | -4.33% |
| 2022 FY | -92.74 Million USD | -20.54% |
| 2022 Q4 | -24.47 Million USD | 7.2% |
| 2022 Q2 | -20.08 Million USD | 7.97% |
| 2021 Q4 | -20.91 Million USD | 4.29% |
| 2021 FY | -76.93 Million USD | -23.8% |
| 2021 Q3 | -21.85 Million USD | -19.01% |
| 2021 Q2 | -18.36 Million USD | 0.0% |
| 2020 FY | -62.14 Million USD | 9.8% |
| 2019 FY | -68.9 Million USD | -34.98% |
| 2018 FY | -51.04 Million USD | -22.95% |
| 2017 FY | -41.52 Million USD | 9.97% |
| 2016 FY | -46.12 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -5275.493% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -1323.06% |
| Evofem Biosciences, Inc. | -17.84 Million USD | -302.23% |
| Nascent Biotech, Inc. | -2.22 Million USD | -3119.278% |
| Rebus Holdings, Inc. | -664 Thousand USD | -10711.145% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 187.702% |
| Qrons Inc. | -643.67 Thousand USD | -11052.488% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -18326.984% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | -29.326% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -17177.889% |
| Skye Bioscience, Inc. | -13.67 Million USD | -425.066% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 1560.606% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -27327.921% |
| SQZ Biotechnologies Company | -75.82 Million USD | 5.327% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -2418.359% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -4573.419% |
| Mesoblast Limited | -84.14 Million USD | 14.69% |
| Marizyme, Inc. | -34.08 Million USD | -110.599% |
| Genus plc | 6.4 Million USD | 1221.656% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 836.837% |
| Pharming Group N.V. | -4.87 Million USD | -1371.162% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -3513.731% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -7607.488% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -759.713% |
| ContraFect Corporation | -56.88 Million USD | -26.186% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -1476.077% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -5020.29% |
| IMV Inc. | -38.67 Million USD | -85.63% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -2509.604% |
| MultiCell Technologies, Inc. | -722.81 USD | -9931417.273% |
| ONE Bio Corp. | 13.68 Million USD | 624.692% |
| Accustem Sciences Inc. | -3.74 Million USD | -1816.123% |
| RVL Pharmaceuticals plc | -58.99 Million USD | -21.692% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -14760.618% |
| Q BioMed Inc. | -3.44 Million USD | -1983.401% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 2127.853% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -2632.08% |
| Biomind Labs Inc. | -1 Million USD | -7010.32% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | -30.586% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -2374.313% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -979.811% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -3750.416% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -239570.139% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -352.345% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -3614.459% |
| GB Sciences, Inc. | -1.42 Million USD | -4953.541% |
| Alpha Cognition Inc. | -9.7 Million USD | -639.635% |
| HST Global, Inc. | -140.9 Thousand USD | -50845.659% |
| CSL Limited | 3.7 Billion USD | 101.939% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -6281.511% |
| Halberd Corporation | -75.05 Thousand USD | -95550.899% |
| Enzolytics Inc. | -2.14 Million USD | -3240.748% |
| Agentix Corp. | -1.37 Million USD | -5133.146% |
| Resverlogix Corp. | -12.74 Million USD | -463.072% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -2165.776% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | 83.111% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -6776.054% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -2358.893% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -4445.273% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -2008.266% |
| AVAX Technologies, Inc. | 6.69 Million USD | 1172.573% |
| Zenith Capital Corp. | -8.94 Million USD | -702.706% |
| Genscript Biotech Corporation | -415.79 Million USD | 82.735% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -411965.897% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -2823.696% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -41755.398% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -3480.783% |
| Kadimastem Ltd | -3.04 Million USD | -2261.187% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -7194.932% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -5615.446% |
| BioStem Technologies, Inc. | -7.77 Million USD | -822.822% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -39454.784% |
| LadRx Corporation | -3.82 Million USD | -1777.433% |
| Cell Source, Inc. | -4.32 Million USD | -1559.659% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -10349.96% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -10349.96% |
| NovAccess Global Inc. | -2.46 Million USD | -2810.133% |
| Affymax, Inc. | -15.04 Million USD | -377.11% |
| Itoco Inc. | -919.14 Thousand USD | -7710.127% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -1593.7% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -6315.192% |
| Mobile Lads Corp. | -554.55 Thousand USD | -12844.91% |
| CytoDyn Inc. | -18.05 Million USD | -297.53% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -285104.609% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -32518.435% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -12611.719% |
| SYBLEU INC | -149.18 Thousand USD | -48020.391% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -3852.277% |
| International Stem Cell Corporation | -663 Thousand USD | -10727.451% |
| Bioxytran, Inc. | -3.82 Million USD | -1779.142% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -136271.581% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -352830.187% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | -97.943% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -4336.712% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -9655.72% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -2207.49% |
| Neutra Corp. | -229.48 Thousand USD | -31181.211% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -309.294% |
| PureTech Health plc | -146.19 Million USD | 50.898% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | -234.026% |
| IXICO plc | -1.43 Million USD | -4895.546% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -656.359% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 41.065% |
| CSL Limited | 3.81 Billion USD | 101.883% |
| Cellectis S.A. | -108.85 Million USD | 34.055% |